Recombinant MET (Telisotuzumab Biosimilar) antibody

Catalog No. ABIN7598028

This Humanized Chimeric antibody specifically detects MET (Telisotuzumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant MET (Telisotuzumab Biosimilar) antibody (ABIN7598028)

Target: MET (Telisotuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This MET (Telisotuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-MET (Telisotuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Telisotuzumab Biosimilar Antibody

Specificity: Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for MET (Telisotuzumab Biosimilar)

Target: MET (Telisotuzumab Biosimilar)

Alternative Name: Telisotuzumab Biosimilar

Target Type: Biosimilar

Background: Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET

UniProt: P08581

CAS-No: 1781223-80-0